About
Specialties: Gene Therapy, Gene Editing, Virology, Ophthalmology, Molecular Biology…
Activity
-
What is the complement system and how is it impacting the immune response to AAV gene therapy? We're thrilled to share this review article published…
What is the complement system and how is it impacting the immune response to AAV gene therapy? We're thrilled to share this review article published…
Liked by Abraham Scaria
-
With a surge of Geographic Atrophy updates coining last year as ‘the year of Geographic Atrophy’ and a wave of new therapeutics on the horizon, 2024…
With a surge of Geographic Atrophy updates coining last year as ‘the year of Geographic Atrophy’ and a wave of new therapeutics on the horizon, 2024…
Liked by Abraham Scaria
-
Looking for an experienced Retina surgical training professional to join my team! DM me if interested and apply directly to the Beacon website.
Looking for an experienced Retina surgical training professional to join my team! DM me if interested and apply directly to the Beacon website.
Liked by Abraham Scaria
Experience & Education
Languages
-
English
-
-
Hindi
-
-
Malayalam
-
More activity by Abraham
-
For the first time in memory, the Commonwealth of Pennsylvania did not appropriate funds to the School of Veterinary Medicine for the fiscal year…
For the first time in memory, the Commonwealth of Pennsylvania did not appropriate funds to the School of Veterinary Medicine for the fiscal year…
Liked by Abraham Scaria
-
Update #Eyedisease #opthalmology #funding #genetherapy #Precisionmedicine Beacon Therapeutics Forbion Syncona Limited Oxford Science Enterprises…
Update #Eyedisease #opthalmology #funding #genetherapy #Precisionmedicine Beacon Therapeutics Forbion Syncona Limited Oxford Science Enterprises…
Liked by Abraham Scaria
-
𝐁𝐞𝐚𝐜𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐑𝐚𝐢𝐬𝐞𝐬 $𝟏𝟕𝟎 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝐒𝐞𝐫𝐢𝐞𝐬 𝐁 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 Beacon Therapeutics Beacon…
𝐁𝐞𝐚𝐜𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐑𝐚𝐢𝐬𝐞𝐬 $𝟏𝟕𝟎 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝐒𝐞𝐫𝐢𝐞𝐬 𝐁 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 Beacon Therapeutics Beacon…
Liked by Abraham Scaria
-
Advent Life Sciences is thrilled to join Beacon Therapeutics in their journey to becoming a leading retinal gene therapy company. We are proud to…
Advent Life Sciences is thrilled to join Beacon Therapeutics in their journey to becoming a leading retinal gene therapy company. We are proud to…
Liked by Abraham Scaria
-
#PortfolioNews - Congratulations to David Fellows and the team at Beacon Therapeutics for securing $170 million in its Series B funding. We are…
#PortfolioNews - Congratulations to David Fellows and the team at Beacon Therapeutics for securing $170 million in its Series B funding. We are…
Liked by Abraham Scaria
-
Beacon Therapeutics Holdings Limited announced it has raised $170 million in Series B funding, which will be used to support the continued clinical…
Beacon Therapeutics Holdings Limited announced it has raised $170 million in Series B funding, which will be used to support the continued clinical…
Liked by Abraham Scaria
-
Delighted to have closed the Series B with a great team. Looking forward to working with investors, old and new, to continue Beacon's mission to…
Delighted to have closed the Series B with a great team. Looking forward to working with investors, old and new, to continue Beacon's mission to…
Liked by Abraham Scaria
-
Beacon Therapeutics has raised another $170 million to take on Johnson & Johnson in a gene therapy race in the rare eye disease XLRP, which can lead…
Beacon Therapeutics has raised another $170 million to take on Johnson & Johnson in a gene therapy race in the rare eye disease XLRP, which can lead…
Liked by Abraham Scaria
-
𝗕𝗲𝗮𝗰𝗼𝗻 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 𝗦𝗲𝗰𝘂𝗿𝗲𝘀 𝟭𝟳𝟬𝗠 𝗦𝗲𝗿𝗶𝗲𝘀 𝗕 Funding will be used for the following 👇 Gene therapies and…
𝗕𝗲𝗮𝗰𝗼𝗻 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 𝗦𝗲𝗰𝘂𝗿𝗲𝘀 𝟭𝟳𝟬𝗠 𝗦𝗲𝗿𝗶𝗲𝘀 𝗕 Funding will be used for the following 👇 Gene therapies and…
Liked by Abraham Scaria
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More